Publication:
Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai children

dc.contributor.authorNottasorn Plipaten_US
dc.contributor.authorTim R. Cresseyen_US
dc.contributor.authorNirun Vanpraparen_US
dc.contributor.authorKulkanya Chokephaibulkiten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherHarvard School of Public Healthen_US
dc.date.accessioned2018-08-24T02:12:20Z
dc.date.available2018-08-24T02:12:20Z
dc.date.issued2007-01-01en_US
dc.description.abstractWe evaluated 19 children using 220-300 mg/m of indinavir (IDV) boosted with 100 mg ritonavir (RTV) (n = 12) or full-dose RTV (n = 7). Geometric mean (GM) (90% confidence interval, CI) of IDV Ctrough in children who took IDV with 100 mg RTV (n = 12) was 0.17 (0.06-0.50) mg/L. For children who took IDV with full-dosage RTV, GM (90% CI) was 0.40 (0.10-1.61) mg/L. C2hours were less than 10 mg/L in all subjects. Eighteen children had good virologic response. This report demonstrates that smaller IDV dosages given with RTV provide efficacious plasma concentrations and can be safely used. © 2007 Lippincott Williams & Wilkins, Inc.en_US
dc.identifier.citationPediatric Infectious Disease Journal. Vol.26, No.1 (2007), 86-88en_US
dc.identifier.doi10.1097/01.inf.0000247140.94669.1ben_US
dc.identifier.issn08913668en_US
dc.identifier.other2-s2.0-33846004830en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/25062
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846004830&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEfficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai childrenen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846004830&origin=inwarden_US

Files

Collections